US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Whitehawk Therapeutics, Inc.

1.93

+0.03001.58%

Post-market: 1.930.00000.00%18:34 EDT

Volume:146.49K

Turnover:277.65K

Market Cap:90.92M

PE:2.11

High:1.94

Open:1.88

Low:1.84

Close:1.90

Loading ...

Overview Company News Filings

Whitehawk Therapeutics Inc. to Participate in H.C. Wainwright "HCW@Home" Series

Whitehawk Therapeutics Inc. Conducted Annual Stockholders Meeting

Whitehawk Therapeutics Unveils ADC-Focused Corporate Presentation Highlighting Tumor Biology and Advanced Platform Technology

Whitehawk Therapeutics Inc. to Present at Jefferies 2025 Global Healthcare Conference

Whitehawk Therapeutics Inc. to Participate in TD Cowen 6th Annual Oncology Innovation Summit

Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Whitehawk Therapeutics Inc expected to post a loss of 46 cents a share - Earnings Preview

BRIEF-Whitehawk Therapeutics Files Prospectus To Offer & Resale, From Time To Time, Of Up To 41.7 Million Shares By Selling Stockholder

WhiteHawk Therapeutics: Files Prospectus to Offer & Resale, From Time to Time, of up to 41.7 Mln Shares by Selling Stockholder

THOMSON REUTERS

BRIEF-Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals

WhiteHawk Therapeutics Completes Strategic Transformation With Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

THOMSON REUTERS

Press Release: Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

BRIEF-Aadi Bioscience Inc changes name to Whitehawk Therapeutics

Aadi Bioscience Inc: Company Shares to Trade on Nasdaq Under Symbol "Whwk" Effective March 19, 2025

THOMSON REUTERS

Aadi Bioscience Inc: Changes Its Name to WhiteHawk Therapeutics

THOMSON REUTERS

Aadi Bioscience Inc expected to post a loss of 22 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/WHWK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WHWK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":1.93,"timestamp":1751054400000,"preClose":1.9,"halted":0,"volume":146489,"hourTrading":{"tag":"盘后","latestPrice":1.93,"preClose":1.93,"latestTime":"18:34 EDT","volume":492,"amount":947.36,"timestamp":1751063655772},"delay":0,"floatShares":21851160,"shares":47109293,"eps":0.914523,"marketStatus":"Market Closed","change":0.03,"latestTime":"06-27 16:00:00 EDT","open":1.88,"high":1.94,"low":1.84,"amount":277654.957622,"amplitude":0.052632,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.914523,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.9,"postHourTrading":{"tag":"盘后","latestPrice":1.93,"preClose":1.93,"latestTime":"18:34 EDT","volume":492,"amount":947.36,"timestamp":1751063655772},"volumeRatio":0.5353302083716159,"impliedVol":1.7168,"impliedVolPercentile":0.9286},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","floatShares":21851160,"roa":"-21.92%","roe":"17.69%","lyrEps":-2.356312,"volumeRatio":0.5353302083716159,"shares":47109293,"dividePrice":0,"high":1.94,"amplitude":0.052632,"preClose":1.9,"low":1.84,"week52Low":1.21,"pbRate":"0.41","psRate":"3.27","week52High":3.812,"institutionHeld":0,"latestPrice":1.93,"eps":0.914523,"divideRate":0,"volume":146489,"delay":0,"ttmEps":0.914523,"open":1.88,"prevYearClose":3.155,"prevWeekClose":2.09,"prevMonthClose":1.69,"prevQuarterClose":1.78,"fiveDayClose":2.09,"twentyDayClose":1.8,"sixtyDayClose":1.7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WHWK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544848161","title":"Whitehawk Therapeutics Inc. to Participate in H.C. Wainwright \"HCW@Home\" Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2544848161","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544848161?lang=en_us&edition=fundamental","pubTime":"2025-06-19 20:00","pubTimestamp":1750334430,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc., a company specializing in oncology therapeutics, will participate in the virtual H.C. Wainwright \"HCW@Home\" series on June 26, 2025. Dave Lennon, PhD, President and CEO, and David Dornan, PhD, Chief Scientific Officer, will represent the company at the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on June 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250619:nNDL2JbD7T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"gpt_icon":0},{"id":"2543630173","title":"Whitehawk Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543630173","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543630173?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:39","pubTimestamp":1749847185,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc. held its annual meeting of stockholders on June 11, 2025. During the meeting, the election of three Class II directors was approved. Additionally, the compensation of executive officers was approved on an advisory basis. The appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL9nNrNK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2541095884","title":"Whitehawk Therapeutics Unveils ADC-Focused Corporate Presentation Highlighting Tumor Biology and Advanced Platform Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2541095884","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541095884?lang=en_us&edition=fundamental","pubTime":"2025-06-05 02:38","pubTimestamp":1749062326,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Unveils ADC-Focused Corporate Presentation Highlighting Tumor Biology and Advanced Platform Technology. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL1TF2mC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"gpt_icon":0},{"id":"2538473020","title":"Whitehawk Therapeutics Inc. to Present at Jefferies 2025 Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2538473020","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538473020?lang=en_us&edition=fundamental","pubTime":"2025-05-28 20:02","pubTimestamp":1748433721,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc. has announced its participation in the Jefferies 2025 Global Healthcare Conference, scheduled for June 3-5, 2025, in New York City. At the event, Dave Lennon, PhD, President and CEO, will present an overview of the company on June 4, 2025, from 2:00-2:30 PM ET. The presentation will be available via a live webcast on the company's IR website and can be replayed for approximately 30 days following the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL8xn3J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2537898015","title":"Whitehawk Therapeutics Inc. to Participate in TD Cowen 6th Annual Oncology Innovation Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2537898015","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537898015?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:00","pubTimestamp":1747828854,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc., an oncology therapeutics company, will participate in the TD Cowen 6th Annual Oncology Innovation Summit on May 28, 2025. The company's president and CEO, Dave Lennon, PhD, is set to engage in a fireside chat during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on May 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL1bBDRc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2534345193","title":"Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2534345193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534345193?lang=en_us&edition=fundamental","pubTime":"2025-05-09 06:07","pubTimestamp":1746742078,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryWhitehawk Therapeutics Inc WHWK.OQ reported quarterly adjusted earnings of $1.83 per share for the quarter e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG3Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK"],"gpt_icon":0},{"id":"2532374849","title":"Whitehawk Therapeutics Inc  expected to post a loss of 46 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532374849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532374849?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:12","pubTimestamp":1746191556,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Inc  expected to post a loss of46cents a share - Earnings Preview Whitehawk Therapeutics Inc WHWK.OQ WHWK.O is expected to show a fall in quarterly revenue when it reports  resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK"],"gpt_icon":0},{"id":"2524905695","title":"BRIEF-Whitehawk Therapeutics Files Prospectus To Offer & Resale, From Time To Time, Of Up To 41.7 Million Shares By Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2524905695","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524905695?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:14","pubTimestamp":1743459295,"startTime":"0","endTime":"0","summary":"BRIEF-Whitehawk Therapeutics Files Prospectus To Offer & Resale, From Time To Time, Of Up To 41.7 Million Shares By Selling StockholderMarch 31  - Whitehawk Therapeutics Inc WHWK.O:WHITEHAWK THERAPEUTICS: FILES PROSPECTUS TO OFFER & RESALE, FROM TIME TO TIME, OF UP TO 41.7 MILLION SHARES BY SELLING STOCKHOLDERSource text: [ID:n0001193125-25-068942]Further company coverage: WHWK.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2524908725","title":"WhiteHawk Therapeutics: Files Prospectus to Offer & Resale, From Time to Time, of up to 41.7 Mln Shares by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2524908725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524908725?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:32","pubTimestamp":1743456744,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","WHWK"],"gpt_icon":0},{"id":"2522745438","title":"BRIEF-Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2522745438","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522745438?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:01","pubTimestamp":1742990482,"startTime":"0","endTime":"0","summary":"BRIEF-Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken PharmaceuticalsMarch 26 (Reuters) - Whitehawk Therapeutics Inc WHWK.O:WHITEH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUABND6CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","WHWK"],"gpt_icon":0},{"id":"2522745718","title":"WhiteHawk Therapeutics Completes Strategic Transformation With Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2522745718","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522745718?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUABND6CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2522087468","title":"Press Release: Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2522087468","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522087468?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990400,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals. This press release contains certain forward-looking statements regarding the business of Whitehawk Therapeutics that are not a description of historical facts within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the Company's current beliefs and expectations and may include, but are not limited to, statements relating to: the Company's cash runway extending into 2028; the anticipated timing of the Company's development of its portfolio of ADC assets, including the expected timing regarding the commencement of IND-enabling studies and key clinical data readouts; expectations regarding the beneficial characteristics, safety, efficacy, therapeutic effects and the size of the potential targeted markets with respect to the Company's ADC assets; and the sufficiency of the Company's existing capita","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4139","WHWK","R","LENZ","BK4022"],"gpt_icon":0},{"id":"2520363955","title":"BRIEF-Aadi Bioscience Inc changes name to Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520363955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520363955?lang=en_us&edition=fundamental","pubTime":"2025-03-19 05:58","pubTimestamp":1742335129,"startTime":"0","endTime":"0","summary":"BRIEF-Aadi Bioscience Inc changes name to Whitehawk TherapeuticsMarch 18 (Reuters) - Aadi Bioscience Inc AADI.O:AADI BIOSCIENCE INC:  CHANGES ITS NAME TO WHITEHAWK THERAPEUTICSAADI BIOSCIENCE INC: COM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADI","WHWK","BK4139"],"gpt_icon":0},{"id":"2520934564","title":"Aadi Bioscience Inc: Company Shares to Trade on Nasdaq Under Symbol \"Whwk\" Effective March 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520934564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520934564?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:15","pubTimestamp":1742328946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WHWK","BK4139","AADI"],"gpt_icon":0},{"id":"2520584934","title":"Aadi Bioscience Inc:  Changes Its Name to WhiteHawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520584934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520584934?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:15","pubTimestamp":1742328946,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WHWK","BK4139","AADI"],"gpt_icon":0},{"id":"2520994525","title":"Aadi Bioscience Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520994525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520994525?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:45","pubTimestamp":1742215546,"startTime":"0","endTime":"0","summary":"Aadi Bioscience Inc  expected to post a loss of22cents a share - Earnings Preview Aadi Bioscience Inc AADI.OQ AADI.O is expected to show a rise in quarterly revenue when it reports  results on March 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q00YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","AADI"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WHWK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"WHWK","fiscalQuarterEnding":"2025/03","expectedEps":-0.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-03-19","symbol":"WHWK","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"WHWK","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-08-07","symbol":"WHWK","fiscalQuarterEnding":"2024/06","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-05-08","symbol":"WHWK","fiscalQuarterEnding":"2024/03","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.68}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WHWK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WHWK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WHWK","date":"2025-06-27","current":3.241387,"percent":0.823529,"low":-1.267109,"twenty":-1.185573,"median":-0.735269,"eighty":3.203855,"high":3.565526,"avg":0.943405,"sd":2.113402,"marketCap":89507656},"quantilePoints":[{"date":"2025-03-21","current":-0.758488,"twenty":-0.777063,"median":-0.770098,"eighty":-0.763132,"marketCap":48308888},{"date":"2025-03-28","current":-0.735269,"twenty":-0.778611,"median":-0.758488,"eighty":-0.745331,"marketCap":46830044},{"date":"2025-04-04","current":-1.204672,"twenty":-1.122401,"median":-0.762358,"eighty":-0.739913,"marketCap":76726773},{"date":"2025-04-11","current":-1.189981,"twenty":-1.212018,"median":-0.793317,"eighty":-0.745331,"marketCap":75791081},{"date":"2025-04-17","current":-1.131217,"twenty":-1.219363,"median":-1.160599,"eighty":-0.754619,"marketCap":72048311},{"date":"2025-04-25","current":-1.10918,"twenty":-1.212018,"median":-1.134889,"eighty":-0.758488,"marketCap":70644773},{"date":"2025-05-02","current":-1.226709,"twenty":-1.212018,"median":-1.131217,"eighty":-0.766228,"marketCap":78130312},{"date":"2025-05-09","current":-1.204672,"twenty":-1.212018,"median":-1.145908,"eighty":-0.781707,"marketCap":76726773},{"date":"2025-05-16","current":2.863258,"twenty":-1.212018,"median":-1.131217,"eighty":-0.743009,"marketCap":79066004},{"date":"2025-05-23","current":3.185163,"twenty":-1.204672,"median":-1.098162,"eighty":2.795488,"marketCap":87955081},{"date":"2025-05-30","current":3.070788,"twenty":-1.204672,"median":-1.083471,"eighty":2.866646,"marketCap":84796727},{"date":"2025-06-06","current":2.866068,"twenty":-1.204672,"median":-0.793317,"eighty":2.88654,"marketCap":79143612},{"date":"2025-06-13","current":3.480226,"twenty":-1.198796,"median":-0.762358,"eighty":2.971113,"marketCap":96102957},{"date":"2025-06-20","current":3.497286,"twenty":-1.192919,"median":-0.748814,"eighty":3.05809,"marketCap":96574050},{"date":"2025-06-27","current":3.241387,"twenty":-1.185573,"median":-0.735269,"eighty":3.203855,"marketCap":89507656}],"updateTime":1751127200875}}}